190 related articles for article (PubMed ID: 27422780)
1. Family Studies for Classification of Variants of Uncertain Classification: Current Laboratory Clinical Practice and a New Web-Based Educational Tool.
Garrett LT; Hickman N; Jacobson A; Bennett RL; Amendola LM; Rosenthal EA; Shirts BH
J Genet Couns; 2016 Dec; 25(6):1146-1156. PubMed ID: 27422780
[TBL] [Abstract][Full Text] [Related]
2. Exploring relatives' perceptions of participation, ethics, and communication in a patient-driven study for hereditary cancer variant reclassification.
Tsai GJ; Chen AT; Garrett LT; Burke W; Bowen DJ; Shirts BH
J Genet Couns; 2020 Oct; 29(5):857-866. PubMed ID: 31916645
[TBL] [Abstract][Full Text] [Related]
3. Power of pedigree likelihood analysis in extended pedigrees to classify rare variants of uncertain significance in cancer risk genes.
Rosenthal EA; Ranola JMO; Shirts BH
Fam Cancer; 2017 Oct; 16(4):611-620. PubMed ID: 28534081
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of 92 patient-driven family studies for reclassification of variants of uncertain significance.
Tsai GJ; Rañola JMO; Smith C; Garrett LT; Bergquist T; Casadei S; Bowen DJ; Shirts BH
Genet Med; 2019 Jun; 21(6):1435-1442. PubMed ID: 30374176
[TBL] [Abstract][Full Text] [Related]
5. Multi-gene panel testing for hereditary cancer susceptibility in a rural Familial Cancer Program.
Hermel DJ; McKinnon WC; Wood ME; Greenblatt MS
Fam Cancer; 2017 Jan; 16(1):159-166. PubMed ID: 27401692
[TBL] [Abstract][Full Text] [Related]
6. Patient goals, motivations, and attitudes in a patient-driven variant reclassification study.
Tsai GJ; Garrett LT; Makhnoon S; Bowen DJ; Burke W; Shirts BH
J Genet Couns; 2019 Jun; 28(3):558-569. PubMed ID: 31163102
[TBL] [Abstract][Full Text] [Related]
7. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
8. Understanding variants of uncertain significance in the era of multigene panels: Through the eyes of the patient.
Reuter C; Chun N; Pariani M; Hanson-Kahn A
J Genet Couns; 2019 Aug; 28(4):878-886. PubMed ID: 31050105
[TBL] [Abstract][Full Text] [Related]
9. Classification and Clinical Management of Variants of Uncertain Significance in High Penetrance Cancer Predisposition Genes.
Moghadasi S; Eccles DM; Devilee P; Vreeswijk MP; van Asperen CJ
Hum Mutat; 2016 Apr; 37(4):331-6. PubMed ID: 26777316
[TBL] [Abstract][Full Text] [Related]
10. The Development and Evaluation of Novel Patient Educational Material for a Variant of Uncertain Significance (VUS) Result in Hereditary Cancer Genes.
Cragun D; Dean M; Baker D; Kelley M; Hooker G; Weidner A; Hunt P; Pal T
Curr Oncol; 2024 Jun; 31(6):3361-3378. PubMed ID: 38920739
[TBL] [Abstract][Full Text] [Related]
11. Rescreening for genetic mutations using multi-gene panel testing in patients who previously underwent non-informative genetic screening.
Frey MK; Kim SH; Bassett RY; Martineau J; Dalton E; Chern JY; Blank SV
Gynecol Oncol; 2015 Nov; 139(2):211-5. PubMed ID: 26296696
[TBL] [Abstract][Full Text] [Related]
12. Variants of uncertain significance (VUS) in cancer predisposing genes: What are we learning from multigene panels?
Lucci-Cordisco E; Amenta S; Panfili A; Del Valle J; Capellá G; Pineda M; Genuardi M
Eur J Med Genet; 2022 Jan; 65(1):104400. PubMed ID: 34813939
[TBL] [Abstract][Full Text] [Related]
13. Sequence Variants of Uncertain Significance: What to Do When Genetic Test Results Are Not Definitive.
Greenblatt MS
Surg Oncol Clin N Am; 2015 Oct; 24(4):833-46. PubMed ID: 26363543
[TBL] [Abstract][Full Text] [Related]
14. Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.
Balmaña J; Digiovanni L; Gaddam P; Walsh MF; Joseph V; Stadler ZK; Nathanson KL; Garber JE; Couch FJ; Offit K; Robson ME; Domchek SM
J Clin Oncol; 2016 Dec; 34(34):4071-4078. PubMed ID: 27621404
[TBL] [Abstract][Full Text] [Related]
15. Factors predicting reclassification of variants of unknown significance.
Wright M; Menon V; Taylor L; Shashidharan M; Westercamp T; Ternent CA
Am J Surg; 2018 Dec; 216(6):1148-1154. PubMed ID: 30217367
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of conflicting variant interpretations in the cancer genetics clinic.
Zukin E; Culver JO; Liu Y; Yang Y; Ricker CN; Hodan R; Sturgeon D; Kingham K; Chun NM; Rowe-Teeter C; Singh K; Zell JA; Ladabaum U; McDonnell KJ; Ford JM; Parmigiani G; Braun D; Kurian AW; Gruber SB; Idos GE
Genet Med; 2023 Jul; 25(7):100837. PubMed ID: 37057674
[TBL] [Abstract][Full Text] [Related]
17. Modeling the impact of data sharing on variant classification.
Casaletto J; Cline M; Shirts B
J Am Med Inform Assoc; 2023 Feb; 30(3):466-474. PubMed ID: 36451272
[TBL] [Abstract][Full Text] [Related]
18. Clinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significance.
Surowy HM; Sutter C; Mittnacht M; Klaes R; Schaefer D; Evers C; Burgemeister AL; Goehringer C; Dikow N; Heil J; Golatta M; Schott S; Schneeweiss A; Bugert P; Sohn C; Bartram CR; Burwinkel B
Breast Cancer Res Treat; 2014 Jun; 145(2):451-60. PubMed ID: 24728577
[TBL] [Abstract][Full Text] [Related]
19. Assessing biases of information contained in pedigrees for the classification of BRCA-genetic variants: a study arising from the ENIGMA analytical working group.
Kerkhofs CH; Spurdle AB; Lindsey PJ; Goldgar DE; Gómez-García EB
Hered Cancer Clin Pract; 2016; 14():10. PubMed ID: 27134689
[TBL] [Abstract][Full Text] [Related]
20. The recommendation of re-classification of variants of uncertain significance (VUS) in adult genetic disorders patients.
Zhang L; Shen M; Shu X; Zhou J; Ding J; Lin H; Pan B; Zhang C; Wang B; Guo W
J Hum Genet; 2024 Jun; ():. PubMed ID: 38839994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
